The results of dose-response relationship analysis also show that with the serum copeptin concentration increasing, the prevalence of ischemic stroke increased (Poverall = 0.002), while the prevalence of hemorrhagic stroke decreased (Poverall = 0.007), just as shown in Figures 2 and 3. The gene discussed is AVP; the disease is hemorrhagic stroke.